Advanced Search

Home > Journals > Minerva Stomatologica > Past Issues > Minerva Stomatologica 2014 October;63(10) > Minerva Stomatologica 2014 October;63(10):341-9



A Journal on Dentistry and Maxillofacial Surgery

Official Journal of the Italian Society of Odontostomatology and Maxillofacial Surgery
Indexed/Abstracted in: CAB, EMBASE, Index to Dental Literature, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index

Frequency: Bi-Monthly

ISSN 0926-4970

Online ISSN 1827-174X


Minerva Stomatologica 2014 October;63(10):341-9


Prognostic factors for surgically resected squamous cell carcinoma of the lower oral cavity

Soares J. M. A. 1, Cançado H. R. 2, Sousa A. A. 3, Moraes G. M. 3, Carvalho J. R. 3, Silva G. S. 3, Porcaro-Salles J. M. 3

1 Head and Neck Surgery Department, General Hospital of São João de Deus, Divinopolis, MG, Brazil;
2 Head and Neck Surgery Department, General Hospital of Baleia, Belo Horizonte, MG, Brazil;
3 Head and Neck Surgery Department, General Hospital of the Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

AIM: The objective of this study was to evaluate the impact of clinical variables on survival rates in patients with squamous cell carcinomas in the lower oral cavity.
METHODS: We conducted a retrospective study of patients who exhibited a histological diagnosis of squamous cell carcinoma of the lower oral cavity, who underwent surgery. Data on clinical, histological, and treatment variables were collected to assess the effect of these variables on global survival and disease-free curves.
RESULTS: We studied 117 patients, 86 (73.5%) males and 31 (26.5%) females, who underwent surgery between January 2005 and June 2009. The overall survival rate was 74.4% after two years, and the disease-free rate was 67.5%. Midline invasion by the primary tumor negatively impacted overall survival (P=0.02) and disease-free survival (P=0.01). The disease-free survival rate of patients with histologically confirmed neck metastases was 76.8% versus 59% for patients without metastases (P=0.01). Disease-free survival of patients with one affected lymph node was 89.5%, and 45.2% for more than one affected lymph node (P<0.01). Patients who ended radiotherapy in less than 60 days exhibited a disease-free rate of 59.0%, and patients whose treatment lasted more than 60 days exhibited a rate of 77.1% (P=0.06).
CONCLUSION: In our study, primary tumor invasion of the midline, the presence of more than one affected lymph node as confirmed by histology, the delaying radiotherapy for more than 56 days and radiotherapy that lasted longer than 60 days worsen patient prognosis.

language: English


top of page